Cargando…

Dihydrotanshinone I inhibits human glioma cell proliferation via the activation of ferroptosis

The aim of the present study was to investigate the effect of dihydrotanshinone I (DHI) on the survival of human glioma cells and the expression levels of ferroptosis-associated proteins. Human U251 and U87 glioma cells were cultured in vitro and treated with different concentrations of DHI and/or t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Shougang, Hou, Xiaoqun, Mei, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448571/ https://www.ncbi.nlm.nih.gov/pubmed/32863935 http://dx.doi.org/10.3892/ol.2020.11980

Ejemplares similares

Dihydrotanshinone I Inhibits the Proliferation and Growth of Oxaliplatin-Resistant Human HCT116 Colorectal Cancer Cells
por: Wang, Mengge, et al.
Publicado: (2022)

Dihydrotanshinone I inhibits hepatocellular carcinoma cells proliferation through DNA damage and EGFR pathway
por: Wang, Linjun, et al.
Publicado: (2023)

Dihydrotanshinone I inhibits ovarian cancer cell proliferation and migration by transcriptional repression of PIK3CA gene
por: Wang, Xiaoqing, et al.
Publicado: (2020)

Dihydrotanshinone I inhibits the growth of osteosarcoma through the Wnt/β-catenin signaling pathway
por: Tan, Tao, et al.
Publicado: (2019)

Effects of Dihydrotanshinone I on Proliferation and Invasiveness of Paclitaxel-Resistant Anaplastic Thyroid Cancer Cells
por: Allegri, Lorenzo, et al.
Publicado: (2021)

Dihydrotanshinone I Specifically Inhibits NLRP3 Inflammasome Activation and Protects Against Septic Shock In Vivo
por: Wei, Ziying, et al.
Publicado: (2021)

15,16-dihydrotanshinone I inhibits EOMA cells proliferation by interfering in posttranscriptional processing of hypoxia-inducible factor 1
por: Duan, Peiwen, et al.
Publicado: (2021)

Regulation of HuR structure and function by dihydrotanshinone-I
por: Lal, Preet, et al.
Publicado: (2017)

ACSL4 suppresses glioma cells proliferation via activating ferroptosis
por: Cheng, Jing, et al.
Publicado: (2020)

Dihydrotanshinone I Inhibits the Lung Metastasis of Breast Cancer by Suppressing Neutrophil Extracellular Traps Formation
por: Zhao, Huan, et al.
Publicado: (2022)

Dihydrotanshinone I Inhibits the Growth of Osteosarcoma Through the Wnt/β-Catenin Signaling Pathway [Retraction]
Publicado: (2023)

Dihydrotanshinone I preconditions myocardium against ischemic injury via PKM2 glutathionylation sensitive to ROS
por: Wu, Xunxun, et al.
Publicado: (2023)

Enhanced Bioavailability of Dihydrotanshinone I–Bovine Serum Albumin Nanoparticles for Stroke Therapy
por: Ren, Yanru, et al.
Publicado: (2021)

Dihydrotanshinone I Alleviates Spinal Cord Injury via Suppressing Inflammatory Response, Oxidative Stress and Apoptosis in Rats
por: Yu, Liuqian, et al.
Publicado: (2020)

Dihydrotanshinone Inhibits Hepatocellular Carcinoma by Suppressing the JAK2/STAT3 Pathway
por: Hu, Xue, et al.
Publicado: (2021)

Dihydrotanshinone-I interferes with the RNA-binding activity of HuR affecting its post-transcriptional function
por: D’Agostino, Vito Giuseppe, et al.
Publicado: (2015)

15, 16-Dihydrotanshinone I Inhibits Hemangiomas through Inducing Pro-apoptotic and Anti-angiogenic Mechanisms in Vitro and in Vivo
por: Cai, Yihong, et al.
Publicado: (2018)

Dihydrotanshinone I protects human chondrocytes and alleviates damage from spontaneous osteoarthritis in a guinea pig model
por: Zhang, Yan-Zhuo, et al.
Publicado: (2023)

Biotransformation of triterpenoid ganoderic acids from exogenous diterpene dihydrotanshinone I in the cultures of Ganoderma sessile
por: Wang, Xinwei, et al.
Publicado: (2023)

The Nrf2-inducers tanshinone I and dihydrotanshinone protect human skin cells and reconstructed human skin against solar simulated UV()
por: Tao, Shasha, et al.
Publicado: (2013)

STAT3-mediated activation of mitochondrial pathway contributes to antitumor effect of dihydrotanshinone I in esophageal squamous cell carcinoma cells
por: Qi, Ming-Ming, et al.
Publicado: (2021)

Dihydrotanshinone I Enhances Cell Adhesion and Inhibits Cell Migration in Osteosarcoma U−2 OS Cells through CD44 and Chemokine Signaling
por: Fan, Lanyan, et al.
Publicado: (2022)

Simultaneous purification of dihydrotanshinone, tanshinone I, cryptotanshinone, and tanshinone IIA from Salvia miltiorrhiza and their anti-inflammatory activities investigation
por: Gao, Hongwei, et al.
Publicado: (2018)

Dihydrotanshinone I Alleviates Crystalline Silica-Induced Pulmonary Inflammation by Regulation of the Th Immune Response and Inhibition of STAT1/STAT3
por: Zhang, Yiting, et al.
Publicado: (2019)

Dihydrotanshinone-Induced NOX5 Activation Inhibits Breast Cancer Stem Cell through the ROS/Stat3 Signaling Pathway
por: Kim, Su-Lim, et al.
Publicado: (2019)

15,16-Dihydrotanshinone I from the Functional Food Salvia miltiorrhiza Exhibits Anticancer Activity in Human HL-60 Leukemia Cells: in Vitro and in Vivo Studies
por: Liu, Jun-Jen, et al.
Publicado: (2015)

Chromosome Doubling-Enhanced Biomass and Dihydrotanshinone I Production in Salvia miltiorrhiza, A Traditional Chinese Medicinal Plant
por: Chen, Elena Gamboa, et al.
Publicado: (2018)

15,16-Dihydrotanshinone I, a Compound of Salvia miltiorrhiza Bunge, Induces Apoptosis through Inducing Endoplasmic Reticular Stress in Human Prostate Carcinoma Cells
por: Chuang, Mao-Te, et al.
Publicado: (2011)

Dihydrotanshinone-I modulates Epithelial Mesenchymal Transition (EMT) Thereby Impairing Migration and Clonogenicity of Triple Negative Breast Cancer Cells
por: Kashyap, Akanksha, et al.
Publicado: (2021)

Activated PKB/GSK-3β synergizes with PKC-δ signaling in attenuating myocardial ischemia/reperfusion injury via potentiation of NRF2 activity: Therapeutic efficacy of dihydrotanshinone-I
por: Zeng, Hao, et al.
Publicado: (2021)

Dihydrotanshinone, a Natural Diterpenoid, Preserves Blood-Retinal Barrier Integrity via P2X7 Receptor
por: Fresta, Claudia Giuseppina, et al.
Publicado: (2020)

TFEB-NF-κB inflammatory signaling axis: a novel therapeutic pathway of Dihydrotanshinone I in doxorubicin-induced cardiotoxicity
por: Wang, Xiaoping, et al.
Publicado: (2020)

Ginsenoside Rh4 Inhibits Colorectal Cancer Cell Proliferation by Inducing Ferroptosis via Autophagy Activation
por: Wu, Yingchao, et al.
Publicado: (2022)

Sophoridine derivative 6j inhibits liver cancer cell proliferation via ATF3 mediated ferroptosis
por: Tian, Kunpeng, et al.
Publicado: (2023)

Inhibition of Glioma Cells’ Proliferation by Doxorubicin-Loaded Exosomes via Microfluidics
por: Thakur, Abhimanyu, et al.
Publicado: (2020)

Prucalopride inhibits the glioma cells proliferation and induces autophagy via AKT-mTOR pathway
por: Qiao, Hong, et al.
Publicado: (2018)

Emerging roles of ferroptosis in glioma
por: Shi, Jiaqi, et al.
Publicado: (2022)

Dihydrotanshinone Triggers Porimin-Dependent Oncosis by ROS-Mediated Mitochondrial Dysfunction in Non-Small-Cell Lung Cancer
por: Zhang, Dongjie, et al.
Publicado: (2023)

Nanomedicine promotes ferroptosis to inhibit tumour proliferation in vivo
por: Luo, Yifeng, et al.
Publicado: (2021)

SSRP1 silencing inhibits the proliferation and malignancy of human glioma cells via the MAPK signaling pathway
por: Liao, Jianming, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_grbqldvq3905sshtlh0b0ah65l